Abstract:Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. It is estimated that 13,410 cases will be diagnosed and 8,990 will die of AML in the United States in 2007 (http://seer.cancer.gov). AML is a genetically diverse hematopoietic malignancy with variable response to treatment. Expression profiling of protein-coding genes using DNA microarray in AML has resulted in inconsistent data from different laboratories. Therefore, further validation of these observations in large cohorts and in independent studies is definitely required before clinical application becomes feasible. Recently, Golub and colleagues described a new, bead-based flow cytometric microRNA (miRNAs, miRs) expression profiling method that could successfully classify tumors. MiRNAs are endogenous ∼22 nucleotide non-coding RNAs, which can function as oncogenes and tumor suppressors. To provide new insights into the complex genetic alterations in leukemogenesis and to identify novel markers for diagnosis and treatment of AML, we performed a genome-wide analysis of miRNA expression profiles using the bead-based method on 54 AML samples with common translocations including t(15;17), t(8;21), inv(16), and 11q23 rearrangement, along with normal controls. In both unsupervised and supervised hierarchical cluster analyses, we observed that t(15;17) samples grouped together as one cluster, as do the 11q23 rearrangement samples. Interestingly, t(8;21) and inv(16), both CBF (core-binding factor) AMLs, grouped together as a unique cluster. Forty-one miRNAs exhibited significantly differential expression between different subtypes of AMLs, and/or between AMLs and normal controls. Notably, expression signature of a minimal number of two, three, and seven miRNAs could be used for class prediction of CBF, t(15;17), and 11q23 rearrangement AMLs, respectively, with an overall diagnostic accuracy of 94–96%. We further showed that overexpression of the two discriminatory miRNAs in CBF AML is associated with epigenetic regulation, rather than DNA copy number amplification. Moreover, several important target genes of these discriminatory miRNAs have also been validated. We are currently exploring the role of these discriminatory miRNAs and their critical target genes in the development of AML using in vitro and in vivo models. This work will enhance our understanding of the biological role of these miRNAs and their targets in leukemogenesis.

[The expression and regulatory mechanism of microRNA-708 in pediatric common B-cell acute lymphoblastic leukemia].

Retracted: Overexpression of Mir-708 and Its Targets in the Childhood Common Precursor B-cell ALL

Retracted: Overexpression Of Mir-708 And Its Targets In The Childhood Common Precursor B-Cell All (Retracted Article. See Vol.64,Pg.0,2017)

Distinct Microrna Expression Profiles In Acute Myeloid Leukemia With Common Translocations

MicroRNA Expression Profiles in Acute Myeloid Leukemia with Common Translocations.

MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia.

MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.

MiR-362-5p As a Novel Prognostic Predictor of Cytogenetically Normal Acute Myeloid Leukemia

Downregulation of Mir-142 Promotes Leukemia Growth in Philadelphia Chromosome-Positive (ph+) Acute Lymphoblastic Leukemia (ALL): A Possible Novel Therapeutic Target?

Correlation of Plasma MiR-146a,MiR-223 Levels with the Prognosis of Childhood with Acute Lymphoblastic Leukemia

Microrna Patterns Associated With Clinical Prognostic Parameters And Cns Relapse Prediction In Pediatric Acute Leukemia

Expression pattern of <i>miR-16-2-3p</i> and its prognostic values on pediatric acute lymphoblastic leukemia

Differential Microrna Expression in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

MicroRNAs and regulated interaction networks reveal differences between adult and pediatric acute myeloid leukemia

Mir-99a May Serve As A Potential Oncogene in Pediatric Myeloid Leukemia

Spectrum and Clinical Features of Gene Mutations in Chinese Pediatric Acute Lymphoblastic Leukemia

The expressions of miR-196b and its prognostic significances in pediatric acute myeloid leukemia

Study of MicroRNA-326 and MicroRNA-200c Expression in Pediatric Acute Lymphoblastic Leukemia

High Expression of Midkine (MK) Indicates Poor Prognosis in Childhood Acute Lymphoblastic Leukemia.

Expression Characteristics and Prognosissignificance of Mirna-181A in Acute Myeloid Leukemia with Normal Karyotype

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF MIR-203 IN PEDIATRIC ACUTE LEUKEMIA